Zobrazeno 1 - 10
of 100
pro vyhledávání: '"Kartik S. Sundareswaran"'
Publikováno v:
ASAIO Journal. 64:754-759
Left ventricular assist device (LVAD) thrombosis is a devastating complication that occurs in about 10% of patients despite anticoagulation and antiplatelet treatment. How the thrombus initiates and propagates is unknown. We pathologically and immuno
Autor:
John M. Stulak, Jason N. Katz, Richa Agarwal, David J. Farrar, Eric Adler, Kartik S. Sundareswaran, Simon Maltais, Igor D. Gregoric, Ranjit John, Sitaramesh Emani, Joyce Chuang, Thenappan Thenappan, Palak Shah, Peter Eckman, Nir Uriel, Mary E. Keebler
Publikováno v:
The Journal of Heart and Lung Transplantation. 37:25-32
Background Hemolysis , assessed by elevated serum lactate dehydrogenase (LDH), is strongly associated with HeartMate II pump thrombosis (PT). However, it is unknown whether early intervention for elevated LDH circumvents the risk of serious PT requir
Autor:
Pooja Singhal, Gregg W. Stone, Hong Nie, Saibal Kar, JoAnn Lindenfeld, Michael J. Mack, Neil J. Weissman, William T. Abraham, Kartik S. Sundareswaran, Federico M. Asch, Paul A. Grayburn, D. Scott Lim
Publikováno v:
JAMA Cardiology. 6:427
Importance Transcatheter mitral valve repair (TMVr) plus maximally tolerated guideline-directed medical therapy (GDMT) reduced heart failure (HF) hospitalizations (HFHs) and all-cause mortality (ACM) in symptomatic patients with HF and secondary mitr
Autor:
Kartik S. Sundareswaran, Laura Damme, D. Farrar, Michael Berchtold-Herz, Pierre-Yves Litzler, Ivan Netuka, Erwan Flecher, Daniel Zimpfer, Jan D. Schmitto
Publikováno v:
The Annals of Thoracic Surgery. 103:1262-1268
Background Current recommendations of antithrombotic therapy for HeartMate II (HMII) patients include the use of both an anticoagulant and an antiplatelet agent. Because bleeding is still the most frequent adverse event, the TRACE (STudy of Reduced A
Autor:
Jason N. Katz, Nader Moazami, Ranjit John, O.H. Frazier, Sangjin Lee, David J. Farrar, Kartik S. Sundareswaran, Ulrich P. Jorde
Publikováno v:
Asaio Journal
There is insufficient data on patients with small body size to determine if this should be considered a risk factor for continuous-flow left ventricular assist device (CF-LVAD) support. We sought to evaluate survival outcomes, adverse events, and fun
Autor:
Joseph G. Rogers, David DeNofrio, David J. Farrar, Michael S. Kiernan, Duc Thinh Pham, Martin Strueber, Naveen L. Pereira, Navin K. Kapur, Kartik S. Sundareswaran
Publikováno v:
Journal of Cardiac Failure. 22:797-805
Background Left ventricular assist devices (LVADs) improve survival, quality of life (QOL), and functional capacity (FC) among patients with end-stage heart failure. Few data are available regarding characteristics associated with QOL and FC response
Publikováno v:
Circulation. 136(19)
We are delighted to see Maltais and colleagues express interest in our efforts to enhance depiction of clinical outcomes in the field of mechanical circulatory support. We welcome this opportunity to help clarify several misconceptions that may have
Autor:
Maria Restrepo, James Bethel, Christopher M. Haggerty, Kartik S. Sundareswaran, Kevin K. Whitehead, Lucia Mirabella, Elaine Tang, Ajit P. Yoganathan, Diane de Zélicourt, Mark A. Fogel
Publikováno v:
The Journal of Thoracic and Cardiovascular Surgery. 148:1481-1489
Objectives This study sought to quantify average hemodynamic metrics of the Fontan connection as reference for future investigations, compare connection types (intra-atrial vs extracardiac), and identify functional correlates using computational flui
Autor:
Christopher T. Salerno, Christiano Caldeira, Gregory A. Ewald, Chetan B. Patel, Poornima Sood, Andrew J. Boyle, Kartik S. Sundareswaran, Joseph C. Cleveland, Antone Tatooles, Mandeep R. Mehra, Nir Uriel, Daniel J. Goldstein, Valluvan Jeevanandam, Ranjit John, Scott C. Silvestry, James W. Long, Paolo C. Colombo
Publikováno v:
Circulation. 135(21)
Background: The HeartMate 3 (HM3) Left Ventricular Assist System (LVAS) (Abbott) is a centrifugal, fully magnetically levitated, continuous-flow blood pump engineered to enhance hemocompatibility and reduce shear stress on blood components. The MOMEN
Autor:
David J. Farrar, Christopher T. Salerno, Thomas P. Schleeter, Kartik S. Sundareswaran, Sina L. Moanie, Mary Norine Walsh
Publikováno v:
The Journal of Heart and Lung Transplantation. 33:809-815
The aim of this study was to evaluate the prevalence of early pump power elevation events in patients with the HeartMate II (HMII) and its impact on subsequent development of stroke and pump thrombosis.We analyzed45,000 measurements of pump power and